Clinician reference tool — not medical advice. This is a clinical decision-aid intended for healthcare professionals: it gives deterministic suggestions to think with, not a diagnosis or a prescription. If you’re a patient, you’re welcome to look around — but please review anything here with your own doctor; it isn’t a substitute for personalized medical care.

Evidence: Macfarlane GJ 2017 · sources last checked 2026-08-20

Reference tool — not medical advice. Thresholds, targets, and first-line agents differ by guideline body and change over time — switch the lens to compare. Clinician judgement, dosing/monitoring, contraindications, and live coverage always required. Runs entirely in your browser — no data is collected.

Fibromyalgia management guide

A management guide for fibromyalgia (a real disorder of central pain processing), anchored on EULAR 2017. EXERCISE is the cornerstone — the only strong-for therapy. Toggle the professional lens (conventional / naturopathic / osteopathic-manual) to see honestly-graded adjuncts, with opioids/corticosteroids/chiropractic flagged to avoid.

Making the diagnosis

Fibromyalgia is a positive clinical diagnosis, not a diagnosis of exclusion. It is made from the symptom pattern, with no confirmatory test. The 2012 Canadian Guidelines ask primary care to make it early, without waiting for a specialist to confirm it. The criteria sets differ, so switch between them to compare.

Diagnostic criteria

20122012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome (Canadian Pain Society + Canadian Rheumatology Association; Fitzcharles MA et al., Pain Res Manag 2013). Still the current Canadian guideline. link

  1. 1Suspect it

    Think of fibromyalgia when there is widespread pain for 3 months or more, together with fatigue, unrefreshing sleep or cognitive symptoms. Headache, irritable bowel and mood symptoms often travel with it.

    In a patient who already has the diagnosis, a new or changing symptom still deserves its own work-up. Don't attribute it to fibromyalgia automatically.

  2. 2Apply the criteria: Canadian 2012

    0/5 documented.

    Optional, rec 6: the ACR criteria “can be used at initial assessment to validate a clinical diagnosis” (level 3, grade B). The guideline cites the 2010 criteria; the worksheet uses the 2016 revision.

  3. 3Examine

    Expect the exam to be normal apart from soft-tissue tenderness on manual palpation. A formal tender-point count is not needed (Canadian 2012, recs 2–3).

    These point elsewhere and need their own work-up:

    • Joints that are visibly swollen, hot, or stiff for more than an hour every morning: points towards inflammatory arthritis, not fibromyalgia
    • New weakness, numbness in a clear pattern, or loss of bladder or bowel control: needs its own neurological work-up
    • Fever, night sweats, or losing weight without trying: needs its own work-up
  4. 4Limited labs to exclude mimics

    Canadian 2012: CBC, ESR, CRP, CK, TSH. No confirmatory test. Any further laboratory or imaging work-up should follow the clinical evaluation of the individual patient. Avoid repeat investigation after diagnosis unless new symptoms or signs appear. (Canadian 2012, recs 4–5)

    AHC approach: the focused rule-out panel in “Should I be tested?” below (approved record, reviewed 2026-10-07). Normal results are the expected finding and do not argue against the diagnosis.

  5. 5Other illnesses

    Diagnose when the symptoms “cannot be explained by some other illness.” Be aware that other conditions can present like FM, and that patients with other medical illnesses may also have FM. (Canadian 2012, recs 1 and 7)

  6. 6Tell the patient

    Give the diagnosis clearly once it is made. A named diagnosis can reduce testing, referrals and visits. Avoid repeat investigation unless new symptoms or signs appear (Canadian 2012, rec 5).

    “There's no blood test that confirms fibromyalgia — a normal result is actually the expected finding, not a sign we've missed something. We'll still run a small panel to rule out things that can look similar, like thyroid problems or anemia. If you have swollen or hot joints, that points away from fibromyalgia, and we'd look into that specifically instead.”

    Point them to the patient page, written for exactly this conversation.

  7. 7Counselling checklist

    Tick what you covered. Each item adds its line to the chart note below.

    With every activity recommendation

    Pair every activity or exercise recommendation with this: listen to your body and don't overdo it; the patient decides the amount and intensity in the moment.

    • K037 is time-based, billed per half-hour unit or major part thereof: 1 unit needs 20 minutes direct patient contact, 2 units 46 minutes, 3 units 76 minutes. Time must be consecutive, direct patient contact, and excludes chart review or other non-patient-facing time. Start and stop times must be recorded in the patient's permanent record or the service is not payable. No other consultation, assessment, visit, or time-based service is payable the same day, same patient, same physician. (Ontario Schedule of Benefits Physician Services effective 2026-07-01, A50; GP7(g); GP55)

  8. 8Chart note

    Fibromyalgia assessment per 2012 Canadian Guidelines (Fitzcharles et al, CPS/CRA).
    Clinical criteria (recs 1-4): 0/5 documented.
    Outstanding: Diffuse body pain for at least 3 months; Fatigue, sleep, cognitive or mood symptoms, to a variable degree; Physical exam within normal limits apart from soft-tissue tenderness (hyperalgesia) on manual palpation; no tender-point count needed; Simple blood tests done and unremarkable (CBC, ESR, CRP, CK, TSH); Symptoms not explained by another illness.
    Assessment: criteria not yet fully documented.
    Red flags (joint swelling, new neurological signs, fever, weight loss) to be documented separately.
    Patient given info page: https://fibromyalgia.ajaxharwoodclinic.com/patient

Management

With every activity recommendation

Pair every activity or exercise recommendation with this: listen to your body and don't overdo it; the patient decides the amount and intensity in the moment.

Guideline lens

Should I be tested?

Last reviewed 2026-10-07

"Should I be tested?" for fibromyalgia

Clinical diagnosis — no single test

Also called: fibromyalgia testing, fibromyalgia diagnosis, is there a test for fibromyalgia, fibromyalgia blood test

After months of widespread pain, patients want a test that proves what's wrong, especially once earlier tests came back normal and they fear that means nothing is wrong, or that they aren't believed. Fibromyalgia is a real, definable clinical diagnosis (ACR 2016 criteria), but it is made from a symptom pattern, not a blood test or scan, a fact this app's clinician page already states plainly.

Raises suspicion

  • • Widespread pain, present on both sides of the body and above and below the waist, for at least 3 months, together with fatigue, unrefreshing sleep, or cognitive symptoms, meeting the ACR 2016 criteria
  • • New or changing symptoms in someone with an existing fibromyalgia diagnosis: these still deserve their own work-up, not automatic attribution to fibromyalgia

Does not raise suspicion

  • • Normal blood tests and scans in someone with a typical fibromyalgia pattern: this is the expected finding, not a sign something was missed
  • • Widespread pain alone, without the associated fatigue, sleep or cognitive symptoms, once the standard limited panel is normal, does not need an open-ended search for more causes

Red flags

  • • Joints that are visibly swollen, hot, or stiff for more than an hour every morning: points towards inflammatory arthritis, not fibromyalgia
  • • New weakness, numbness in a clear pattern, or loss of bladder or bowel control: needs its own neurological work-up
  • • Fever, night sweats, or losing weight without trying: needs its own work-up

Who to test

  • Meeting the clinical pattern for fibromyalgia (widespread pain 3+ months plus fatigue, sleep, or cognitive symptoms), tested to exclude mimics rather than to confirm fibromyalgia: Complete blood count (CBC) (Situation-specific), Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) (Situation-specific), Creatine kinase (CK) (Situation-specific), TSH (thyroid stimulating hormone) (Standard)CRP only from the ESR/CRP entry. The Canadian 2012 guideline frames the work-up as a ceiling: 'testing limited to' simple blood tests, with anything more depending on the clinical evaluation suggesting another condition. Following Choosing Wisely Canada (Medical Biochemistry #2), CRP replaces the guideline's ESR-and-CRP pair. AAPT 2019 also lists a comprehensive metabolic panel as 'sometimes obtained'; it is not added. Vitamin D is not routinely needed unless a specific deficiency risk factor is present.
  • Age 50 or over with new shoulder or hip-girdle stiffness or constitutional symptoms, or suspected inflammatory arthritis or connective-tissue disease: Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) (Situation-specific)Add ESR to CRP here (to assess for polymyalgia rheumatica, giant cell arteritis or myeloma, or inflammatory disease). AHC clinical direction (Dr. Yu, 2026-10-07).
  • Joint swelling or other findings suggesting inflammatory arthritis: Rheumatoid factor (RF) (Situation-specific)Only order with actual joint findings on exam, not for widespread pain alone.
  • Specific features suggesting lupus or another connective tissue disease: Antinuclear antibody (ANA) (Situation-specific)Only order with specific features (rash, unexplained low blood counts, kidney disease, inflammatory arthritis), not as a general screen for widespread pain.

More likely instead

Counselling script

“There's no blood test that confirms fibromyalgia — a normal result is actually the expected finding, not a sign we've missed something. We'll still run a small panel to rule out things that can look similar, like thyroid problems or anemia. If you have swollen or hot joints, that points away from fibromyalgia, and we'd look into that specifically instead.”

Chart snippet (OSCAR-safe plain text)

Concern discussed, not tested

Concern re: fibromyalgia diagnosis/testing discussed.
Discriminating features: widespread pain 3+ months with fatigue, unrefreshing sleep, or cognitive symptoms per ACR 2016 criteria; reviewed.
Red flags: joint swelling, new weakness, fever, weight loss; absent.
Assessment: clinical pattern reviewed; normal labs expected and do not argue against the diagnosis.
Plan: focused rule-out panel considered, CBC and TSH plus CK/ANA/RF only if specific features present; no open-ended testing.
Ref: ACR 2016 criteria (Wolfe et al); 2012 Canadian Guidelines (Fitzcharles et al, Canadian Pain Society).
Patient given info page: https://fibromyalgia.ajaxharwoodclinic.com/patient
Revisit if: joint swelling, new neurological signs, fever, or weight loss develop.

Testing ordered

Concern re: fibromyalgia diagnosis/testing discussed.
Discriminating features: widespread pain 3+ months with fatigue, unrefreshing sleep, or cognitive symptoms per ACR 2016 criteria; red flags absent.
Assessment: focused rule-out testing appropriate; normal results expected and consistent with the diagnosis.
Plan: CBC and TSH ordered; ANA and rheumatoid factor added only given specific joint or systemic features.
Ref: ACR 2016 criteria (Wolfe et al); 2012 Canadian Guidelines (Fitzcharles et al, Canadian Pain Society).
Patient given info page: https://fibromyalgia.ajaxharwoodclinic.com/patient
Revisit if: joint swelling, new neurological signs, fever, or weight loss develop.

Revisit if

  • • Joint swelling, new neurological signs, fever, or unintentional weight loss develop
  • • Symptoms change character or stop fitting the pattern over time
  • • New muscle weakness or pain develops in someone on a statin

References

  1. 1. American College of Rheumatology (Wolfe F et al.). 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria (2016)The 2016 ACR criteria: fibromyalgia may be diagnosed in adults meeting the physician-based criteria, valid for individual patient diagnosis
  2. 2. Canadian Pain Society / Canadian Rheumatology Association (Fitzcharles MA et al.). 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary (2012)— older guidelineDescribes fibromyalgia as a clinical construct without a defining physical abnormality or biological marker
  3. 3. College of Family Physicians of Canada / Choosing Wisely Canada. Family Medicine: Fifteen Tests and Treatments to Question (2026)Recommends against routine vitamin D testing in fibromyalgia
  4. 4. College of Family Physicians of Canada / Choosing Wisely Canada. Family Medicine: Fifteen Tests and Treatments to Question (2026)Guides thyroid screening as part of the fibromyalgia rule-out work-up
  5. 5. Canadian Rheumatology Association / Choosing Wisely Canada. Rheumatology: Eleven Tests and Treatments to Question (2024)ANA only indicated with specific signs or symptoms suggestive of SLE, not as a general screen
  6. 6. Canadian Rheumatology Association / Choosing Wisely Canada. Rheumatology: Eleven Tests and Treatments to Question (2024)Rheumatoid factor only indicated with clinically suspicious arthralgia or arthritis found on exam
  7. 7. ACTTION-APS Pain Taxonomy (AAPT) / American Academy of Pain Medicine, American Pain Society (Arnold LM et al.). AAPT Diagnostic Criteria for Fibromyalgia (2019)Screening laboratory tests sometimes obtained in fibromyalgia include ESR and/or CRP, CBC, a comprehensive metabolic panel, and thyroid function test; routine RF or ANA testing is not recommended unless autoimmune features are present or initial inflammatory indices are abnormal
  8. 8. Canadian Association of Medical Biochemists / Choosing Wisely Canada. Choosing Wisely Canada: Medical Biochemistry, Ten Tests and Treatments to Question (Canadian Association of Medical Biochemists), recommendation #2: erythrocyte sedimentation rate (ESR) (2026)Don't order an ESR to screen asymptomatic patients or as a general test for inflammation in undiagnosed conditions; CRP is the preferred measure of systemic inflammation
Evidence notes

Widened from CBC + TSH (with CK only for statin use or objective weakness) to CBC, CRP, creatine kinase and TSH, i.e. the Canadian 2012 baseline panel with CRP alone in place of ESR and CRP (Dr. Yu, 2026-10-07, following Choosing Wisely Canada Medical Biochemistry #2; ESR added only for age 50+ with new girdle stiffness or constitutional symptoms, or suspected inflammatory arthritis or connective-tissue disease), because the approved record was narrower than the only dedicated Canadian fibromyalgia guideline we hold, without a sourced reason for the narrower cut. Fitzcharles et al, rec 4 [2]: 'FM should be diagnosed as a clinical construct, without any confirmatory laboratory test, and with testing limited to simple blood testing including a full blood count and measurement of erythrocyte sedimentation rate and levels of C-reactive protein, creatine kinase and thyroid stimulating hormone. Any additional laboratory or radiographic testing should depend on the clinical evaluation in an individual patient that may suggest some other medical condition' (level 5, grade D; 2012, now 14 years old, flagged older_than_10y; no more recent Canadian update found). AAPT 2019 [7] is broadly concordant: it lists ESR and/or CRP, CBC, and thyroid function test alongside this panel, framed descriptively ('screening laboratory tests are sometimes obtained') rather than as a graded recommendation, and additionally names a comprehensive metabolic panel; that panel is not added to the AHC approach here, since no Canadian source requires it and AAPT itself only describes it as sometimes obtained. The previously open gap, that TestSelect had no entry for creatine kinase or for a standard, non-cardiovascular ESR/CRP, is closed by the two new records drafted alongside this edit (creatine-kinase, esr-crp); hs-crp remains a separate record restricted to cardiovascular risk stratification and stays unlinked here. The stand-alone statin-or-weakness-triggered CK row is removed because creatine kinase is now part of the baseline panel for everyone meeting the clinical pattern, under the same 'testing limited to' framing; new muscle weakness in someone on a statin remains a revisit_if trigger regardless of this change. RF and ANA rows are unchanged: both Canadian sources agree these are only indicated with specific joint or systemic features, not as part of the baseline panel.

Guidelines

References

  1. [1]Macfarlane GJ, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 2017;76:318 (non-pharm first; exercise the ONLY strong-for; opioids/corticosteroids/chiropractic strong-against; CBT/duloxetine/pregabalin weak-for). link
  2. [2]Fitzcharles MA, et al. Canadian Guidelines for the Diagnosis and Management of Fibromyalgia (2012/2013); Canadian Pain Society + Canadian Rheumatology Association. Only pregabalin + duloxetine are Health-Canada-approved for FM. ACR 2016 diagnostic criteria (Wolfe F, et al.). link
  3. [3]Cochrane reviews — acupuncture (CD007070), amitriptyline (CD011824); tai chi RCT (NEJM 2010). Supplement evidence (vitamin D/magnesium/SAMe/CoQ10) is low-quality with real interaction risks (serotonin syndrome, hypermagnesemia, warfarin). link
  4. [4]Balneotherapy/hydrotherapy (EULAR weak-for, best passive modality); massage (EULAR weak-against); OMT sham-controlled RCT negative (PMC8053754). link
  5. [5]Wolfe F, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 2016;46:319-329. WPI >= 7 & SSS >= 5, or WPI 4-6 & SSS >= 9; generalized pain in >= 4 of 5 regions; >= 3 months; valid irrespective of other diagnoses. Physician-based criteria valid for individual diagnosis; the self-report version is not. link
  6. [6]Arnold LM, et al. AAPT Diagnostic Criteria for Fibromyalgia. J Pain 2019;20(6):611-628. >= 6 of 9 pain sites + moderate-to-severe sleep problems or fatigue, >= 3 months. link